Novartis Pharmaceuticals
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1996 |
| Headquarters | Basel , Switzerland |
| Products | Medications and vaccines |
| Parent | Novartis |
Novartis Pharmaceuticals is a division of the Swiss multinational pharmaceutical company Novartis, headquartered in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world, known for developing, manufacturing, and marketing a wide range of medications and vaccines. The company focuses on a variety of therapeutic areas, including oncology, neurology, immunology, and cardiology.
History[edit | edit source]
Novartis Pharmaceuticals was formed in 1996 through the merger of Ciba-Geigy and Sandoz, two Swiss companies with a long history in the pharmaceutical industry. The merger was aimed at creating synergies in the development and marketing of pharmaceutical products.
Products[edit | edit source]
Novartis Pharmaceuticals has developed several notable drugs, including:
- Gleevec (imatinib), used in the treatment of multiple cancers, most notably chronic myeloid leukemia.
- Cosentyx (secukinumab), for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.
- Entresto (sacubitril/valsartan), for heart failure.
Research and Development[edit | edit source]
The company invests heavily in R&D, focusing on innovative therapies that address significant unmet medical needs. Novartis Pharmaceuticals has been involved in the development of gene therapies and personalized medicine, leveraging cutting-edge technologies such as CRISPR and CAR-T cell therapy.
Controversies[edit | edit source]
Novartis Pharmaceuticals has faced several controversies, including issues related to pricing and patenting of medications. The company has been involved in legal disputes over drug patents and has faced criticism over the high cost of some of its medications.
Corporate Social Responsibility[edit | edit source]
Novartis Pharmaceuticals engages in various corporate social responsibility (CSR) initiatives, focusing on access to healthcare, patient advocacy, and sustainable business practices. The company has programs aimed at improving access to medications in developing countries.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
